Zenicor Medical Systems Valuation

Is ZENI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ZENI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ZENI's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ZENI's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ZENI?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for ZENI. This is calculated by dividing ZENI's market cap by their current preferred multiple.
What is ZENI's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	SEK 26.89m

ZENI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.4x
Enterprise Value/EBITDA	-28.1x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does ZENI's PS Ratio compare to its peers?

The above table shows the PS ratio for ZENI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	10.4x
PLUN ProstaLund	2.1x	n/a	SEK 36.9m
PERP B Perpetua Medical	3.4x	n/a	SEK 21.5m
FLUI Fluicell	26.6x	n/a	SEK 34.5m
ODIN Odinwell	9.3x	n/a	SEK 44.4m
ZENI Zenicor Medical Systems	0.8x	n/a	SEK 26.9m

Price-To-Sales vs Peers: ZENI is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (6.9x).

Price to Earnings Ratio vs Industry

How does ZENI's PE Ratio compare vs other companies in the SE Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	32.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	32.8%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: ZENI is good value based on its Price-To-Sales Ratio (0.8x) compared to the Swedish Medical Equipment industry average (4.8x).

Price to Sales Ratio vs Fair Ratio

What is ZENI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ZENI PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.8x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ZENI's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.